Transgenic mice expressing either human proinsulin cDNA or mutated pro
insulin cDNA in the liver were created. The human proinsulin cDNA was
mutated to generate a protein cleavable by the ubiquitous prohormone c
onvertase furin, thus leading to mature insulin peptide, All transgeni
c lines expressed human C-peptide in the blood, whose level varied acc
ording to nutritional conditions, High performance liquid chromatograp
hy fractionation of mouse serum revealed that mutant proinsulin was ef
fectively processed into mature insulin in vivo. This transgenic mouse
model provides a useful tool for further prospects of gene therapy of
insulin-dependent diabetes mellitus. (C) 1998 Federation of European
Biochemical Societies.